Evonik Achieves 2025 Performance Guidance and Confirms 2026 Earnings Outlook

Due to a decline in selling prices and unfavorable exchange rates, sales in this business segment fell by 2%, reaching 5.97 billion euros. Sales volume increased slightly.

The sales of the animal nutrition business achieved a slight increase. The business saw an increase in sales volume, but the selling price declined, with a more significant drop in the second half of the year. The organic chemistry business also achieved growth in sales volume. Some high-performance plastics, such as products used in 3D printing, films, and foam materials, benefited from increased demand. The crosslinking agents business faced significant price pressure due to intensified competition. Overall, despite the increase in sales volume, it was not enough to offset the negative impacts of the price decline and exchange rate fluctuations. The inorganic chemistry business saw a decrease in sales due to a slight decline in sales volume and adverse exchange rate effects, although prices remained relatively stable overall.

This was mainly due to declining sales prices and adverse exchange rate effects, resulting in an 8% decline in adjusted EBITDA for this business segment to €944 million, and a decrease in adjusted EBITDA margin from 16.8% in the same period last year to 15.8%.

Sales declined by 4% to €5.49 billion due to lower volumes and adverse currency effects. Selling prices saw a slight recovery.

In the additives business, the demand for additives used in polyurethane foams, durable consumer goods, as well as in the coatings and paints industry, has declined; the sales volume of oil additives, however, has increased slightly. Despite relatively stable selling prices, the sales revenue of the additives business has significantly decreased due to the impact of sales volume and exchange rate factors. The revenue from the care business remained at the previous year's level, with a slight improvement in prices and overall stable sales volume.

Despite improved sales prices, the adjusted EBITDA for this business segment amounted to €909 million, a 7% decline year-on-year, and the adjusted EBITDA margin decreased from 17.0% in the same period last year to 16.6%, due to lower sales volume and adverse exchange rate effects.